[1] |
Riphagen S, Gomez X, Gonzalez-Martinez C, et al. Hyperinflammatory shock in children during COVID-19 pandemic[J]. Lancet, 2020, 395(10237):1607-8.
doi: S0140-6736(20)31094-1
pmid: 32386565
|
[2] |
Paediatric multisystem inflammatory syndrome temporally associated with COVID-19 (PIMS)-guidance for clinicians[EB/OL]. https://www.rcpch.ac.uk/resources/paediatric-multisystem-inflammatory-syndrome-temporally-associated-covid-19-pims-guidance. 2020-05-01/2023-02-25.
|
[3] |
Multisystem inflammatory syndrome in children (MIS-C) associated with coronavirus disease 2019 (COVID-19)[EB/OL]. https://emergency.cdc.gov/han/2020/han00432.asp. 2020-05-14/2023-02-25.
|
[4] |
Multisystem inflammatory syndrome in children and adolescents with COVID-19[EB/OL]. https://www.who.int/publications/i/item/multisystem-inflammatory-syndrome-in-children-and-adolescents-with-covid-19. 2020-05-15/2023-02-25.
|
[5] |
Feldstein LR, Rose EB, Horwitz SM, et al. Multisystem inflammatory syndrome in us children and adolescents[J]. N Engl J Med, 2020, 383(4):334-346.
doi: 10.1056/NEJMoa2021680
URL
|
[6] |
Toubiana J, Poirault C, Corsia A, et al. Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France: Prospective observational study[J]. BMJ, 2020, 369:m2094.
|
[7] |
Mamishi S, Movahedi Z, Mohammadi M, et al. Multisystem inflammatory syndrome associated with SARS-CoV-2 infection in 45 children: a first report from Iran[J]. Epidemiol Infect, 2020, 148: e196, 1-5.
|
[8] |
Chinniah K, Bhimma R, Naidoo K L, et al. Multisystem inflammatory syndrome in children associated with SARS-CoV-2 infection in KwaZulu-Natal, South Africa[J]. Pediatr Infect Dis J, 2023, 42(1): e9-e14.
doi: 10.1097/INF.0000000000003759
pmid: 36476527
|
[9] |
Kim H, Shim JY, Ko JH, et al. Multisystem inflammatory syndrome in children related to COVID-19: The first case in Korea[J]. Korean Med Sci, 2020, 35(43): e391.
doi: 10.3346/jkms.2020.35.e391
URL
|
[10] |
Yamaguchi Y, Takasawa K, Irabu H, et al. Infliximab treatment for refractoryCOVID-19-associated multisystem inflammatory syndrome in a Japanese child[J]. J Infect Chemother, 2022, 28(6): 814-818.
doi: 10.1016/j.jiac.2022.01.011
pmid: 35125343
|
[11] |
Mishra B, Mishra B, Mohapatra A, et al. Clinical profile and outcomes of multisystem inflammatory syndrome in children: A multicentric observational study[J]. Cureus, 2022, 14(9): e28821.
|
[12] |
Dufort EM, Koumans EH, Chow EJ, et al. Multisystem inflammatory syndrome in children in New York State[J]. N Engl J Med, 2020, 383(4): 347-358.
doi: 10.1056/NEJMoa2021756
URL
|
[13] |
Lima-Setta F, De Magalhaes-Barbosa MC, Rodrigues-Santos G, et al. Multisystem inflammatory syndrome in children(MIS-C) during SARS-CoV-2 pandemic in Brazil: a multicenter, prospective cohort study[J]. Jornal De Pediatria, 2021, 97(3): 354-361.
doi: 10.1016/j.jped.2020.10.008
URL
|
[14] |
Valverde I, Singh Y, Sanchez-De-Toledo J, et al. Acute cardiovascular manifestations in 286 children with multisystem inflammatory syndrome associated with COVID-19 infection in Europe[J]. Circulation, 2021, 143(1): 21-32.
doi: 10.1161/CIRCULATIONAHA.120.050065
pmid: 33166189
|
[15] |
Belhadjer Z, Méot M, Bajolle F, et al. Acute heart failure in multisystem inflammatory syndrome in children in the context of global SARS-CoV-2 pandemic[J]. Circulation, 2020, 142(5):429-436.
doi: 10.1161/CIRCULATIONAHA.120.048360
URL
|
[16] |
Feleszko W, Okarska-Napierala M, Buddingh EP, et al. Pathogenesis, immunology, and immune-targeted management of the multisystem inflammatory syndrome in children (MIS-C) or pediatric inflammatory multisystem syndrome (PIMS): EAACI position paper[J]. Pediatr Allergy Immunol, 2023, 34(1): e13900.
doi: 10.1111/pai.v34.1
URL
|
[17] |
Olivotto S, Basso E, Lavatelli R, et al. Acute encephalitis in pediatric multisystem inflammatory syndrome associated with COVID-19[J]. Ur J Paediatr Neuro, 2021, 34: 84-90.
|
[18] |
Siracusa L, Cascio A, Giordano S, et al. Neurological complications in pediatric patients with SARS-CoV-2 infection: a systematic review of the literature[J]. Ital J Pediatr, 2021, 47(1):123.
doi: 10.1186/s13052-021-01066-9
pmid: 34078441
|
[19] |
Akcay N, Ogur M, Menentoglu ME, et al. Acute cerebellitis in MIS-C: A case report[J]. Pediatr Infect Dis J, 2022, 41(1): E16-E8.
doi: 10.1097/INF.0000000000003358
URL
|
[20] |
Ganguly M, Nandi A, Banerjee P, et al. A comparative study of IL-6, CRP and NT-proBNP levels in post-COVID multisystem inflammatory syndrome in children (MISC) and Kawasaki disease patients[J]. Int J Rheum Dis, 2022, 25(1): 27-31.
doi: 10.1111/apl.v25.1
URL
|
[21] |
Kostik MM, Bregel LV, Avrusin IS, et al. Distinguishing between multisystem inflammatory syndrome, associated with covid-19 in children and the Kawasaki disease: Development of preliminary criteria based on the data of the retrospective multicenter cohort study[J]. Front Pediatr, 2021, 9: 787353.
doi: 10.3389/fped.2021.787353
URL
|
[22] |
Henderson LA, Canna SW, Friedman KG, et al. American college of rheumatology clinical guidance for multisystem inflammatory syndrome in children associated with SARS-CoV-2 and hyperinflammation in pediatric COVID-19: Version 3[J]. Arthritis Rheumatol, 2022, 74(4): E1-E20.
|
[23] |
Bottari G, Severini F, Markowich AH, et al. Hemoadsorption for severe MIS-C in critically ill children, should we consider it as a therapeutic opportunity?[J]. Int J Artif Organs, 2022, 45(10): 871-877.
doi: 10.1177/03913988221111179
URL
|
[24] |
Lalwani P, Baskaran S, Uribe DA, et al. A Case of COVID-19-associated pediatric multisystem inflammatory syndrome in shock managed by cytokine filtration[J]. Case Rep Pediatr, 2022: 3373289.
|
[25] |
Jiang L, Tang K, Irfan O, et al. Epidemiology, clinical features, and outcomes of multisystem inflammatory syndrome in children (MIS-C) and adolescents-a live systematic review and meta-analysis[J]. Curr Pediatr Rep, 2022, 10(2): 19-30.
doi: 10.1007/s40124-022-00264-1
|